Cargando…

(411) Safety and Efficacy of Monoclonal Antibodies Against Sars-Cov-2 in a Heart Transplant Population

PURPOSE: The COVID-19 pandemic has been an unprecedented situation, possibly more so for immunocompromised individuals at higher risk for infection and serious complications. While vaccinations are available, immunocompromised patients are unlikely to mount a significant immune response. Monoclonal...

Descripción completa

Detalles Bibliográficos
Autores principales: Brink, H., Stoller, D., Lowes, B., Lundgren, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068083/
http://dx.doi.org/10.1016/j.healun.2023.02.426